This inventor holds 1 USPTO granted patent. Top assignee: University of Michigan. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Hebao Yuan: Innovator in Viral Infection Treatments
Introduction
Hebao Yuan is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. His innovative work has led to the development of a patent that addresses critical health challenges, including those posed by COVID-19.
Latest Patents
Hebao Yuan holds a patent for "Remdesivir and remdesivir analogs, solutions, and nanoparticle, liposomal, and microparticle compositions for treating viral infections." This invention relates to methods, compounds, and compositions designed to treat viral infections, specifically targeting COVID-19. The patent outlines various embodiments of the compositions, which include remdesivir analogs, surfactants, cyclodextrins, nanoparticles, liposomes, and microparticles. These compositions can be administered intravenously or inhaled as a dry powder, showcasing their versatility in treating infected subjects.
Career Highlights
Hebao Yuan is affiliated with the University of Michigan, where he conducts research and develops innovative solutions for viral infections. His work is characterized by a commitment to advancing medical science and improving patient outcomes. With a focus on practical applications, Yuan's inventions are poised to make a significant impact in the healthcare sector.
Collaborations
Hebao Yuan has collaborated with notable colleagues, including Duxin Sun and Wei Gao. These partnerships enhance the research and development process, fostering an environment of innovation and shared expertise.
Conclusion
Hebao Yuan's contributions to the field of viral infection treatments exemplify the importance of innovation in medicine. His patent for remdesivir analogs and compositions represents a significant advancement in the fight against viral diseases. Through his work at the University of Michigan and collaborations with esteemed colleagues, Yuan continues to push the boundaries of medical research and development.